Basic Information
| LncRNA/CircRNA Name | SNHG11 |
| Synonyms | NA |
| Region | GRCh38_20:38446578-38450921 |
| Ensemble | ENSG00000174365 |
| Refseq | NR_003239 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | RNA-seq |
| Sample | prostate cancer tissue |
| Expression Pattern | differential expression |
| Function Description | In our results, LINC00476, MALAT1, SNHG11, LINC00649, and ILF3-AS1 are the lncRNAs which have the most nodes and higher BC values and considered as prognostic markers in PCa. |
| Pubmed ID | 30906477 |
| Year | 2019 |
| Title | Identification of prognostic biomarkers of prostate cancer with long non coding RNA-mediated competitive endogenous RNA network. |
External Links
| Links for SNHG11 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |